China is Socialistisch: Het westerse ultrakapitalistische fabeltje

quote:

Op zaterdag 17 augustus 2024 12:16 schreef Mikeytt het volgende:

[..]
Die hebben ze alleen niet.

quote:

Op zaterdag 17 augustus 2024 12:28 schreef Mikeytt het volgende:

[..]
Geinig wel. Waarom is de afbeelding cropped van beneden? Staat een watermerk op dat westerse media niet laten zien.

Ook wel leuk dat je ook nooit de andere kant van de afbeelding laat zien, die aantoont dat dit een afkickkliniek is in Xinjiang
[ afbeelding ]

quote:

Op zaterdag 17 augustus 2024 12:19 schreef Mikeytt het volgende:

[..]
Ik heb met veel Oeigoeren in China gesproken hoor. Zijn vooral blij met het beleid.
Die mensen hebben veel vrienden en familie die geradicaliseerd zijn door invloed bij de grens met Afghanistan. Die zijn vooral boos om de radicalisatie, niet om de heropvoedingskampen die ze weer bij het rechte eind leren leven.

En waarom zou je een heropvoedingskamp willen zien? Er zijn mensen die aan het rehabiliteren zijn. Het is geen dierentuin. Westers gedachtegoed, het leed van mensen gebruiken als een dagje aapjes kijken...

quote:

Op zaterdag 17 augustus 2024 12:15 schreef Mikeytt het volgende:

[..]
China staat boven de meeste westerse landen op de World Innovation index.

En ze investeren ieder jaar fors meer in innovatie

quote:

Op zaterdag 17 augustus 2024 13:18 schreef Mutsaers__78 het volgende:

[..]
Ok, noem 1 innovatieve uitvinding van de Chinezen.

Ik kan er letterlijk geen één bedenken.

quote:

Op zaterdag 17 augustus 2024 11:37 schreef nostra het volgende:
Ah ja, de fabel van het socialisme als tussenstap naar het Werkelijke Communisme. Worked out nicely, Vladimir en Karl.

quote:

Op zaterdag 17 augustus 2024 17:21 schreef Mikeytt het volgende:

[..]
Zelfs de meest bevooroordeelde experts zullen China geen totalitaire dictatuur noemen.
Ze zijn in naam en daad een volksrepubliek.

quote:

Op zaterdag 17 augustus 2024 12:15 schreef Mikeytt het volgende:

[..]
China staat boven de meeste westerse landen op de World Innovation index.

En ze investeren ieder jaar fors meer in innovatie

quote:

Voor publieke onderzoekslaboratoria geldt een sterke hiërarchie:

• 20 nationale labs zijn de topinstituten van China. Twee daarvan richten zich op medisch onderzoek: de
National Lab on Major Disease Research (georganiseerd door het Peking Union Medical College)
en het National Lab for Protein Science (gehost door het Institute of Biophysics).

• 500 lagere laboratoria's ondersteunen deze, waarvan er 65 zich richten op medisch onderzoek (excl
traditionele Chinese geneeskunde), georganiseerd door universiteiten, ziekenhuizen en bedrijven.

• Er bestaan ​​lager in de hiërarchie meer soorten onderzoeksinstituten en technische centra. Met name heeft de NMPA (Nationale Medische Producten Administratie) in 2018 een programma voor medische onderzoekslaboratoria aangekondigd, hierop volgde goedkeuring van 117 laboratoria in twee batches. 30 van deze labs richten zich op medische technologie.

Bron: https://merics.org/sites/(...)ber%202023_final.pdf

quote:

China’s BCI Companies
According to a Chinese ministry report, in 2023 there were more than 100 BCI companies in China, up from around half that number two years prior. A survey of the Chinese BCI industry in the technology news journal 36Kr noted that “outside of the medical scene, BCI companies have their sights on the brain science research market, mainly domestic brain science and brain-like research, neuroscience, language and cognitive function, psychology research and other laboratories, and on providing scientific research tools and services.”

The following ten Chinese BCI companies and one industry association surfaced while doing Internet searches on scientists and institutions for this study, or as the secondary affiliations of authors who contributed to the corpus of papers. Within this sample are companies whose business models address both the therapeutic and cognitive facilitation aspects of BCI.

Neuracle (博睿康)
Neuracle was established in 2011 by a team from Tsinghua University’s Neural Engineering Laboratory (神经工程实验室) and continues to benefit from the association. The company specializes in the research, development, and production of non-invasive and minimally invasive (微创脑机接口) BCIs. Its main customers include several of the universities highlighted above. The company’s wireless EEG acquisition system and transcranial electrical stimulation products are used in biomedicine, psychology, cognitive science, neuroscience, and neuromodulation.

NeuraMatrix (宁矩科技)
NeuraMatrix is another company incubated by Tsinghua University. Stood up in 2019, it builds active implantable systems interfacing with the human body and artificial devices.Whereas China has decades of experience with non-invasive BCI systems, NeuraMatrix was China’s first company to build an implantable device. Unlike other Chinese BCI projects whose goal is to alleviate disability, NeuraMatrix openly states its aim to augment the cognitive power of people in general “by effectively merging human and artificial intelligence.” Its products include electrode materials, a neural interface chip, and “infinite multi-point interface equipment.”

Zhiran Medical (智冉医疗)
Zhiran was founded in Beijing in 2022, with composite experience dating back a decade. The company offers “precise diagnosis and treatment of neurological diseases.” It was created by Fang Ying (方英)—a researcher at China’s National Center for Nanoscience and Technology (国家纳米科学中心) and former Harvard student—and by current CEO Song Qi (宋麒), a University of Iowa PhD recipient, who worked at GE’s Global R&D Center in New York. Their team researches neural tassel electrodes (神经流苏电极) and ultra-flexible micro-electrode arrays.

Xinzhida Neurotechnology (芯智达神经技术)
Also located in Beijing, Xinzhida Neurotechnology was founded in March 2023 under Luo Minmin’s (罗敏敏). management. Luo is co-director of the Chinese Institute for Brain Research (北京脑科学与类脑研究中心), which studies brain-inspired AI and BCI. The firm appears to be a brokerage operation, whose main business is “technology transfer, promotion and exchange.” Xinzhida leads the Intelligent Brain-Computer System Enhancement Program (智能脑机系统增强计划) stood up in April 2023 to integrate Beijing area BCI resources and “build the world's leading brain-computer interface equipment.”

Stairmed (阶梯医疗)
Founded in August 2021 in Shanghai, Stairmed builds implantable BCIs aimed at human body function restoration and function enhancement (机能增强). The company produces “ultra-flexible micro-nano electrodes (超柔性微纳电极) yielding a “spatial sampling density” of 1024 channels/cubic mm. Stairmed was founded by Zhao Zhengtuo (赵郑拓), a researcher at CAS’s Center for Excellence in Brain Science and Intelligence Technology (脑科学与智能技术卓越创新中心) and by Li Xue (李雪), also at CEBSIT and head of its Multimodal Neural Interface Research Group. Zhao’s PhD is from the University of Texas at Austin. Li earned his PhD at Rice University.

Tianqiao and Chrissy Chen Institute (陈天桥雒芊芊研究院)
Founded at Caltech in 2016 by online gaming pioneer Chen Tianqiao (陈天桥) and his spouse Chrissy Luo (雒芊芊), the institute established in 2020 and 2021 two “Frontier Labs” (前沿实验室) for brain research, one at Huashan Hospital (华山医院) in Shanghai headed by neuroscientist Gerwin Schalk, the other at the Shanghai Mental Health Center (上海精神卫生中心), whose vision statement reads: “To enrich people’s lives with brain- and mind-related technology.” The institute intends to extend the development of its invasive BCI products beyond therapeutics to cognitive augmentation.

NeuroXess (脑虎科技)
NeuroXess, also in Shanghai, produces invasive BCI products aimed at “twinning” (孪生) human and artificial intelligence. Its “flexible BCI system” benchmarks the U.S. company Neuralink’s products and was inspired by work that its founder Tao Hu (陶虎) did at Tufts University. Tao, who is also at CAS’s Shanghai Institute of Microsystem and Information Technology (上海微系统与信息技术研究所), aims at cognitive augmentation and a merger with AI. Along the way, BCI will support “emotional regulation and cognitive assessment.”105 Tao predicts the “digitization of humans” through BCI.

Neuracom (衷华脑机)
Neuracom was founded by Huang Li (黄立) in 2021. The company offers “a one-stop implantable brain-computer interface system” claimed to be on a par with the world’s best. Neuracom is part of Wuhan’s China Optics Valley Brain Science Industrial Base (中国光谷脑科学产业基地) in the city’s East Lake High-tech Development Zone (东湖高新区), which is host to Huazhong University of Science and Technology’s Brain Institute, CAS’s Institute of Automation, and other leading organizations, whose collective goal is to build “the first brain-computer interaction industrialization project in Central China.”

BrainCo (强脑科技)
BrainCo, with branches in Hangzhou, Shenzhen, and Boston, was founded in 2015 by Han Bicheng (韩璧丞) and a team of fellow Chinese students at the Harvard Innovation Lab. Besides Harvard, BrainCo’s website lists MIT, Yale University, Boston University, and other foreign entities as collaborators. Its products, based on non-invasive technology, include a bionic hand, an “intelligent” prosthetic leg, neurofeedback sleep aids and an attention-monitoring headband that debuted in a Zhejiang elementary school. BrainCo claims to have funding in excess of USD 200 million and U.S. FDA approval for its products.

We-Linking (微灵医疗)
We-Linking was established in April 2019 in Shenzhen with branches in Beijing, Suzhou, and Maryland and is credited as being a “full-suite” producer of invasive BCI products. Its founder, Li Xiaojian (李骁健) is affiliated with CAS’s Shenzhen Institutes of Advanced Technology (深圳先进技术研究院) and, like many of the entrepreneurs listed here, trained and worked extensively in the United States. In November 2023, the company and its CAS affiliate established a Brain-Computer Intelligent Integration Technology Joint Laboratory (脑机智能融合技术联合实验室) for implantable BCI.

Brain-Computer Interface Industry Alliance (脑机接口产业联盟)
This BCI industrial alliance—China’s first—was formed in February 2023 under Ministry of Industry and Information Technology auspices with support from Tsinghua and other major institutions. It is led by Yu Xiaohui (余晓晖), head of the China Academy of Information and Communications Technology (中国信息通信研究院). Its secretary-general Li Wenyu (李文宇) stated in May 2023 that Chinese researchers have experimented on humans and other primates using implantable and interventional (介入式) technology. As of November 2023, some 151 BCI-related organizations had joined.

Bron: https://cset.georgetown.e(...)-interface-research/